[HTML][HTML] SARS-CoV-2-specific immune response and the pathogenesis of COVID-19

E Gusev, A Sarapultsev, L Solomatina… - International journal of …, 2022 - mdpi.com
The review aims to consolidate research findings on the molecular mechanisms and
virulence and pathogenicity characteristics of coronavirus disease (COVID-19) causative …

Epidemiology and organ specific sequelae of post-acute COVID19: a narrative review

E Korompoki, M Gavriatopoulou, RS Hicklen… - Journal of Infection, 2021 - Elsevier
Objectives “Long COVID”, a term coined by COVID-19 survivors, describes persistent or new
symptoms in a subset of patients who have recovered from acute illness. Globally, the …

Morphological, cellular, and molecular basis of brain infection in COVID-19 patients

F Crunfli, VC Carregari, FP Veras… - Proceedings of the …, 2022 - National Acad Sciences
Although increasing evidence confirms neuropsychiatric manifestations associated mainly
with severe COVID-19 infection, long-term neuropsychiatric dysfunction (recently …

[HTML][HTML] COVID-19 and cognitive impairment: neuroinvasive and blood‒brain barrier dysfunction

Y Chen, W Yang, F Chen, L Cui - Journal of Neuroinflammation, 2022 - Springer
Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has led to a global pandemic. Although COVID-19 …

SARS‐CoV‐2 and the brain: A review of the current knowledge on neuropathology in COVID‐19

A Maiese, AC Manetti, C Bosetti, F Del Duca… - Brain …, 2021 - Wiley Online Library
Abstract SARS‐CoV‐2 (severe acute respiratory syndrome coronavirus 2), the new
coronavirus responsible for the pandemic disease in the last year, is able to affect the central …

[HTML][HTML] Prevalence of headache in patients with coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis of 14,275 patients

MA Islam, SS Alam, S Kundu, T Hossan… - Frontiers in …, 2020 - frontiersin.org
Background: Coronavirus disease 2019 (COVID-19) started to spread globally since
December 2019 from Wuhan, China. Headache has been observed as one of the clinical …

[HTML][HTML] SARS-CoV-2 productively infects human brain microvascular endothelial cells

RC Yang, K Huang, HP Zhang, L Li, YF Zhang… - Journal of …, 2022 - Springer
Background The emergence of the novel, pathogenic severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) has caused a global health emergency. SARS-CoV-2 is highly …

Association of COVID-19 with comorbidities: An update

S Chatterjee, LV Nalla, M Sharma… - ACS Pharmacology & …, 2023 - ACS Publications
Coronavirus disease (COVID-19) is caused by severe acute respiratory syndrome-
coronavirus-2 (SARS-CoV-2) which was identified in Wuhan, China in December 2019 and …

Exploring the Paradox of COVID‐19 in Neurological Complications with Emphasis on Parkinson's and Alzheimer's Disease

SN Rai, N Tiwari, P Singh, AK Singh… - Oxidative medicine …, 2022 - Wiley Online Library
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is a human coronavirus
(HCoV) that has created a pandemic situation worldwide as COVID‐19. This virus can …

[HTML][HTML] Cognitive decline following acute viral infections: literature review and projections for post-COVID-19

RF Damiano, BF Guedes, CC de Rocca… - European archives of …, 2022 - Springer
Recently, much attention has been drawn to the importance of the impact of infectious
disease on human cognition. Several theories have been proposed, to explain the cognitive …